Rasi Laboratories, Inc.
Cranbury, NJ, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Rasi Laboratories, Inc. is a dietary supplement manufacturer in Cranbury, NJ, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.
- Website
- rasilabs.com
- Phone
- 732-873-8500
- Facilities listed
- 1
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
Manufacturing (1)
320 Half Acre Road, Cranbury, NJ 08512, United States
- Coating
- Dry Formulation
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
How Rasi Laboratories, Inc. compares
Among the 769 manufacturers we list, as of our last check.
- One of 28 capsule manufacturers we list in New Jersey, and 325 in the United States. All capsule manufacturers in the USA · All in New Jersey
- One of 23 tablet manufacturers we list in New Jersey, and 228 in the United States. All tablet manufacturers in the USA · All in New Jersey
- One of 24 powder manufacturers we list in New Jersey, and 316 in the United States. All powder manufacturers in the USA · All in New Jersey
FDA recall records
No food or dietary supplement recall found under the name Rasi Laboratories, Inc. in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 6 food or dietary supplement inspections at facilities matching Rasi Laboratories, Inc., from 2010 to 2023, as of . 2 found no objectionable conditions, 3 found conditions the firm was left to correct, and 1 led FDA to recommend official action.
No action indicated · No objectionable conditions found
Inspected
Cranbury, New Jersey
FEI 2245465
No action indicated · No objectionable conditions found
Inspected
Cranbury, New Jersey
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
1 citation posted:
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
Full citation text
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
3 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Quality control operations - returned dietary supplement (21 CFR 111.130)
Full citation text
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.
Quality control operations - returned dietary supplement (21 CFR 111.130)
You do not have quality control operations for returned dietary supplements.
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
1 citation posted:
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
Full citation text
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for purity, strength, and composition of the finished batch of the dietary supplement.
FEI 2245465
Show all 6 inspections
No action indicated · No objectionable conditions found
Inspected
Cranbury, New Jersey
FEI 2245465
No action indicated · No objectionable conditions found
Inspected
Cranbury, New Jersey
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
1 citation posted:
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
Full citation text
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
3 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Quality control operations - returned dietary supplement (21 CFR 111.130)
Full citation text
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.
Quality control operations - returned dietary supplement (21 CFR 111.130)
You do not have quality control operations for returned dietary supplements.
FEI 2245465
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Cranbury, New Jersey
1 citation posted:
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
Full citation text
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for purity, strength, and composition of the finished batch of the dietary supplement.
FEI 2245465
Official action indicated · Regulatory or administrative action recommended
Inspected
Cranbury, New Jersey
10 citations posted:
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
- Quality control - ensure quality; package, labeled, master record (21 CFR 111.105)
- Sampling plans; establish, follow (21 CFR 111.315(b))
See all 10 citations
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for identity, purity, strength, and composition of the finished batch of the dietary supplement.
Quality control - ensure quality; package, labeled, master record (21 CFR 111.105)
Your quality control personnel did not ensure that your manufacturing operations ensure the quality of the dietary supplement.
Sampling plans; establish, follow (21 CFR 111.315(b))
You did not follow sampling plans for obtaining representative samples.
Hold - temperature, humidity, light (21 CFR 111.455(a))
You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.
Training--operations, GMPs, written procedures (21 CFR 211.25(a))
Employees are not given training in the particular operations they perform as part of their function and written procedures required by current good manufacturing practice regulations.
Identity Testing of Each Component (21 CFR 211.84(d)(1))
The identity of each component of a drug product is not verified by conducting at least one test to verify the identity, using specific identity tests if they exist.
Investigations of discrepancies, failures (21 CFR 211.192)
There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Complete test data included in records (21 CFR 211.194(a))
Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.
Procedures to be written and followed (21 CFR 211.198(a))
Procedures describing the handling of all written and oral complaints regarding a drug product are not followed.
FEI 2245465
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What we checked, and what we didn’t
Confirmed from NSF’s public listing
Last checked
- NSF/ANSI 455-2 GMP certification
- 1 facility address
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like organic, kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026